Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07046585

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

Status
Recruiting
Phase
Study type
Observational
Enrollment
25,000 (estimated)
Sponsor
Natera, Inc. · Industry
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.

Detailed description

Participants who meet study inclusion criteria will be invited to enroll in the study and will provide written consent prior to study procedures. Participants will provide blood samples and will be required to have a colonoscopy performed within 120 days of their blood draw. No test results from the blood collection will be provided to participants or clinicians.

Conditions

Timeline

Start date
2025-05-30
Primary completion
2027-07-10
Completion
2033-09-30
First posted
2025-07-01
Last updated
2025-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07046585. Inclusion in this directory is not an endorsement.

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC) (NCT07046585) · Clinical Trials Directory